We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LYPHF market cap is 1.39B. The company's latest EPS is CNY 0.1416 and P/E is 2.61.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 6.36B | 5.54B | 5.2B | 5.98B | 6.14B |
| Operating Income | 1.74B | 1.19B | 162.76M | 857.67M | 1.12B |
| Net Income | 1.4B | 706.59M | -134.39M | 604.81M | 532.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 19.41B | 20.63B | 22.58B | 24.25B | 25.49B |
| Total Liabilities | 10.49B | 12.53B | 13.47B | 13.21B | 11.96B |
| Total Equity | 8.92B | 8.1B | 9.11B | 11.04B | 13.53B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 1.42B | 1.03B | 182.37M | 1.65B | 1.6B |
| Investing | -2.63B | 138.2M | -3.44B | -1.66B | -1.42B |
| Financing | 1.84B | 253.98M | 1.88B | 54.15M | 841.6M |
| Market Cap | 1.39B |
| Price to Earnings Ratio | 2.61 |
| Price to Sales Ratio | 0.23 |
| Price to Cash Ratio | 0.43 |
| Price to Book Ratio | 0.1 |
| Dividend Yield | - |
| Shares Outstanding | 3.76B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 500 |
| 52 Week Change | -13.59% |
| 52 Week High | 0.4282 |
| 52 Week Low | 0.37 |
| Spread (Intraday) | 78.8k (100%) |
| Company Name | Luye Pharma Group Ltd (PK) |
| Address |
clarendon house hamilton HM 11 |
| Website | https://www.luye.cn |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
